Ava specializes in new developments in the field of medical technology related to female reproductive health by bringing together artificial intelligence and clinical research. The Ava bracelet is the firm's first product for the consumer market and uses state-of-the-art sensor technology together with clinically proven methods to pinpoint a woman's fertile days in real time. Ava has received USD 42.6 million of funding to date and is based in Zürich, San Francisco, Belgrade and Makati.